Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Lexicon Genetics to provide knockout mice for BASF

Dec. 16, 1999

The Rockefeller University designs inhibitors of enzyme involved in melatonin biosynthesis

Dec. 15, 1999

Abgenix and CuraGen to develop genomics-based human antibody drugs

Dec. 15, 1999

Diversa and TerraGen Discovery crosslicense patents

Dec. 14, 1999

Cambridge Drug Discovery teams up with universities to exploit protein-targeting technology

Dec. 14, 1999

UCL-1848 as a new tool: the most potent nonpeptide SK channel blocker reported to date

Dec. 9, 1999

DepoMed forms joint venture with Elan for gastric retention delivery technologies

Dec. 8, 1999

Aurora Biosciences announces two new collaborations with Merck

Dec. 7, 1999

MetaPhore awarded grants for research on metal-related therapeutics

Dec. 6, 1999

Abgenix enters human antibody drug collaboration with Human Genome Sciences

Dec. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...